ParCuR-一种新型的人工智能启用步行线索可穿戴设备,用于帕金森病患者
Telmo Lopes1, Manuel Reis Carneiro2, Ana Morgadinho3
1Institute of Systems and Robotics, Department of Electrical and Computer Engineering, University of Coimbra, 3030-290 Coimbra, Portugal.
Sensors (Basel, Switzerland)
|November 27, 2025
概括
一个新的可穿戴设备ParCuR可以实时检测帕金森病患者的步态结. 这种低成本的脚穿戴解决方案提供了自动感官线索,以改善移动性和减少跌倒.
科学领域:
- 生物医学工程 生物医学工程
- 神经科学是一个神经科学.
- 康复技术 康复技术 康复技术
背景情况:
- 步态结 (FoG) 是晚期帕金森病 (PD) 中的一个衰弱的运动症状.
- 现有的FOG预警系统往往是昂贵的,不舒服的和明显的.
- 需要谨慎,有效和个性化的解决方案来管理FOG.
研究的目的:
- 开发和评估ParCuR,这是一种用于对帕金森病患者实时FOG检测和提示的新型可穿戴设备.
- 评估ParCuR系统的可行性,可用性和可靠性.
- 通过解决 FoG 情节来改善患者的流动性和生活质量.
主要方法:
- 开发ParCuR,一个紧的,脚穿戴的可穿戴设备,配有惯性传感器,触觉刺激器和基于AI的软件.
- 使用DAPHNet数据集训练一个用于FoG检测的分类器,评估患者特定和患者独立的模型.
- 与PwP进行小规模试验,以评估可用性和可靠性,并根据反改进设计.
主要成果:
- 该ParCuR设备是手表大小,谨慎,舒适的日常使用.
- 在线检测算法实现了94.9%的灵敏度和91.3%的特异性用于FoG检测使用14个基于频率的功能.
- 自动感官暗示在FOG发作开始后的0.7秒内触发.
结论:
- ParCuR是一种可行的,低成本的可穿戴解决方案,用于个性化,实时的FoG检测和响应式提示.
- 该设备通过改善移动性和最大限度地减少不适,有效地协助PwP.
- 这项技术有可能显著提高帕金森病症状的管理.
相关概念视频
Parkinson's Disease: Treatment
953
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
953
Parkinson's Disease: Overview
1.7K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.7K


